| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| BeOne Medicines Ltd. | SPONSORED ADS | 07725L102 | $2,129,986,760 | 8,799,053 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,093,617,028 | 30,743,275 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $925,281,603 | 42,896,690 | SOLE | |||
| Insmed Incorporated | COM PAR $.01 | 457669307 | $776,226,256 | 7,712,900 | SOLE | |||
| Summit Therapeutics Inc. | COM | 86627T108 | $717,624,887 | 33,722,974 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $598,022,088 | 1,976,018 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $354,147,281 | 5,604,483 | SOLE | |||
| Revolution Medicines, Inc. | COM | 76155X100 | $344,537,320 | 9,364,972 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $290,268,362 | 6,651,429 | SOLE | |||
| Alkermes plc | SHS | G01767105 | $183,407,352 | 6,410,603 | SOLE | |||
| Replimune Group, Inc. | COM | 76029N106 | $102,611,171 | 11,045,336 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $100,815,081 | 2,772,692 | SOLE | |||
| Edgewise Therapeutics, Inc. | COM | 28036F105 | $95,780,873 | 7,305,940 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $94,412,945 | 27,525,640 | SOLE | |||
| Immunovant, Inc. | COM | 45258J102 | $87,326,096 | 5,457,881 | SOLE | |||
| GRAIL, Inc. | COM | 384747101 | $83,821,028 | 1,630,125 | SOLE | |||
| Kiniksa Pharmaceuticals International, plc | ORD SHS CL A | G52694109 | $78,158,591 | 2,824,669 | SOLE | |||
| Bicycle Therapeutics plc | SPONSORED ADS | 88786108 | $75,653,231 | 10,885,357 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $72,884,945 | 2,322,656 | SOLE | |||
| Celcuity Inc. | COM | 15102K100 | $72,763,441 | 5,450,445 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $64,568,128 | 17,310,490 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $54,708,687 | 10,168,901 | SOLE | |||
| Stoke Therapeutics, Inc. | COM | 86150R107 | $52,594,061 | 4,633,838 | SOLE | |||
| Denali Therapeutics Inc. | COM | 24823R105 | $52,206,413 | 3,731,695 | SOLE | |||
| Structure Therapeutics Inc. | SPONSORED ADS | 8.6366E+110 | $52,031,828 | 2,508,767 | SOLE | |||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | $44,535,663 | 2,118,728 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $44,217,404 | 3,882,125 | SOLE | |||
| Roivant Sciences Ltd. | SHS | G76279101 | $42,462,802 | 3,767,773 | SOLE | |||
| BioNTech SE | SPONSORED ADS | 09075V102 | $39,279,232 | 368,923 | SOLE | |||
| Entrada Therapeutics, Inc. | COM | 29384C108 | $32,698,304 | 4,865,819 | SOLE | |||
| Merus N.V. | COM | N5749R100 | $30,212,230 | 574,377 | SOLE | |||
| Praxis Precision Medicines, Inc. | COM | 74006W207 | $28,992,970 | 689,488 | SOLE | |||
| Intellia Therapeutics, Inc. | COM | 45826J105 | $25,097,822 | 2,675,674 | SOLE | |||
| Viridian Therapeutics, Inc. | COM | 92790C104 | $24,386,796 | 1,744,406 | SOLE | |||
| Monte Rosa Therapeutics, Inc. | COM | 61225M102 | $22,171,588 | 4,916,095 | SOLE | |||
| Verona Pharma plc | SPONSORED ADS | 925050106 | $21,171,071 | 223,843 | SOLE | |||
| Vaxcyte, Inc. | COM | 92243G108 | $20,835,171 | 640,885 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $20,814,067 | 37,760 | SOLE | |||
| Verve Therapeutics, Inc. | COM | 92539P101 | $18,995,882 | 1,691,530 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $18,166,220 | 12,883,844 | SOLE | |||
| Disc Medicine, Inc. | COM | 254604101 | $17,850,168 | 337,050 | SOLE | |||
| Akero Therapeutics, Inc. | COM | 00973Y108 | $17,322,257 | 324,630 | SOLE | |||
| Blueprint Medicines Corporation | COM | 09627Y109 | $16,091,461 | 125,538 | SOLE | |||
| Sera Prognostics, Inc. | CLASS A COM | 81749D107 | $15,229,931 | 5,498,170 | SOLE | |||
| Arrowhead Pharmaceuticals, Inc. | COM | 04280A100 | $14,838,949 | 939,174 | SOLE | |||
| Neurogene Inc. | COM | 64135M105 | $14,825,780 | 991,691 | SOLE | |||
| Dianthus Therapeutics, Inc. | COM | 252828108 | $14,713,210 | 789,759 | SOLE | |||
| Celldex Therapeutics, Inc. | COM | 15117B202 | $13,540,280 | 665,370 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADS | 23306J309 | $13,386,507 | 1,461,425 | SOLE | |||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | $11,587,510 | 370,208 | SOLE |